US Patent No: 7,074,555

Number of patents in Portfolio can not be more than 2000

Detection of West Nile Virus

ALSO PUBLISHED AS: 20050244814
1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method and device for detecting a West Nile Virus (WNV) infection including contacting a biological sample from a subject with an anti-IgM antibody and a recombinant WNV E polypeptide and detecting whether the polypeptide substantially binds to an antibody in the sample. The invention also includes a method and device for determining whether an animal is infected with West Nile Virus (WNV), or is either not infected or is vaccinated with a WNV vaccine.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
IDEXX LABORATORIES, INC.WESTBROOK, ME159

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chandrashekar, Ramaswamy Fort Collins, CO 43 175
Esty, Katherine Jean Westbrook, ME 4 6

Cited Art Landscape

Patent Info (Count) # Cites Year
 
CONOCO INC. (1)
2003/0022,949 Fischer-tropsch processes and catalysts using polyacrylate matrix structures 1 2002
 
MERIAL (1)
2003/0104,008 Recombinant vaccine against west nile virus 11 2002
 
MERIAL LIMITED (1)
* 2004/0037,848 Recombinant vaccine against West Nile Virus 10 2003
 
Other [Check patent profile for assignment information] (1)
2003/0148,261 Compositions and methods comprising West Nile virus polypeptides 14 2002
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
CRUCELL HOLLAND B.V. (5)
8,052,974 Host cell specific binding molecules capable of neutralizing viruses and uses thereof 0 2006
7,537,764 Binding molecules capable of neutralizing west nile virus and uses thereof 7 2006
7,244,430 Binding molecules capable of neutralizing West Nile virus and uses thereof 8 2007
8,211,431 Human binding molecules having killing activity against staphylococci and uses thereof 0 2007
8,460,666 Human binding molecules having killing activity against staphylococci and uses thereof 0 2012
 
Other [Check patent profile for assignment information] (1)
8,911,738 Host cell specific binding molecules capable of neutralizing viruses and uses thereof 0 2011
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 11, 2018
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00